Wendell Potter, Center for Public Integrity/Center for Media and Democracy/NATION ON THE TAKE: How Big Money Corrupts Our Democracy and What We Can Do About It, joins Thom. It’s the same story with a different drug. Just a few weeks after Mylan NV faced public outrcy about the skyrocketing price of EpiPens – another pharmaceutical company – Valeant – is under fire for the price of something known. Used to treat serious and potentially fatal cases of lead poisoning – Calcium EDTA is a vital part of any poison control inventory. Recently – however – it’s become very – very expensive. After Valeant purchased the rights to Calcium EDTA in 2013 – it lifted the price of a standard 7 pack from $950 to more than $7,000. It then hiked the price even higher from that $7,000 mark to more than $26,000. As result – many hospitals and poison control centers are having trouble affording a drug that they use to have no problem acquiring. This – of course – is just the latest pricing controversy facing Valeant Pharmaceuticals. Back in April – its executives were grilled by Elizabeth Warren and other Senators on Capitol for doing pretty much the same thing with different drugs. Of course – what we’re seeing here with Calcium EDTA is just one example of systemwide problem with the American health system – a system that forces us to pay more for lifesaving drugs than anyone else in the developed world.

SHARE
Thom is a four-time Project Censored-award-winning, New York Times best-selling author. His national daily progressive radio talk show is distributed to radio stations nationwide by Westwood One, Pacifica, and Free Speech TV. More people listen daily to the Thom Hartmann Program than any other progressive talk show in the nation.